Q1 EPS Forecast for Tenet Healthcare Increased by Analyst

Tenet Healthcare Co. (NYSE:THC) – Analysts at Leerink Partnrs increased their Q1 2025 earnings per share estimates for shares of Tenet Healthcare in a note issued to investors on Wednesday, October 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $2.56 per share for the quarter, up from their prior forecast of $2.50. The consensus estimate for Tenet Healthcare’s current full-year earnings is $10.72 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q2 2025 earnings at $2.75 EPS and Q4 2025 earnings at $4.19 EPS.

Other research analysts have also recently issued research reports about the stock. UBS Group upped their price target on shares of Tenet Healthcare from $180.00 to $197.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Truist Financial boosted their price objective on Tenet Healthcare from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Monday, October 14th. The Goldman Sachs Group boosted their price target on shares of Tenet Healthcare from $156.00 to $173.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. KeyCorp began coverage on Tenet Healthcare in a report on Friday, October 11th. They set an “overweight” rating and a $200.00 price objective on the stock. Finally, Wells Fargo & Company boosted their target price on Tenet Healthcare from $175.00 to $195.00 and gave the company an “overweight” rating in a research note on Tuesday, October 22nd. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and four have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $157.24.

Tenet Healthcare Price Performance

THC stock opened at $139.77 on Monday. Tenet Healthcare has a 12 month low of $51.04 and a 12 month high of $171.20. The company has a current ratio of 1.45, a quick ratio of 1.38 and a debt-to-equity ratio of 2.53. The firm has a market capitalization of $13.65 billion, a P/E ratio of 5.42, a price-to-earnings-growth ratio of 0.80 and a beta of 2.14. The firm has a 50 day moving average of $159.85 and a 200-day moving average of $140.77.

Tenet Healthcare announced that its Board of Directors has approved a stock buyback program on Wednesday, July 24th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the company to reacquire up to 10.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Tenet Healthcare

In other news, Director Meghan Fitzgerald sold 20,000 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $146.34, for a total transaction of $2,926,800.00. Following the completion of the transaction, the director now directly owns 15,269 shares in the company, valued at approximately $2,234,465.46. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider R. Scott Ramsey sold 11,599 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $162.06, for a total value of $1,879,733.94. Following the transaction, the insider now owns 6,324 shares in the company, valued at approximately $1,024,867.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Meghan Fitzgerald sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $146.34, for a total transaction of $2,926,800.00. Following the completion of the transaction, the director now owns 15,269 shares of the company’s stock, valued at approximately $2,234,465.46. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 128,203 shares of company stock valued at $19,754,997 in the last three months. Company insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Innealta Capital LLC purchased a new position in Tenet Healthcare in the 2nd quarter worth about $28,000. ORG Wealth Partners LLC purchased a new position in shares of Tenet Healthcare during the third quarter valued at approximately $30,000. ORG Partners LLC purchased a new stake in Tenet Healthcare in the second quarter worth approximately $31,000. Blue Trust Inc. grew its position in Tenet Healthcare by 93.0% in the 2nd quarter. Blue Trust Inc. now owns 249 shares of the company’s stock worth $33,000 after purchasing an additional 120 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at $34,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.